TITLE

Editorial to conference proceedings

AUTHOR(S)
Bear, C.; Shori, D. K.
PUB. DATE
November 2001
SOURCE
Pflugers Archiv European Journal of Physiology;Nov2001 Supplement 1, Vol. 443, pS1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on the First International Conference on the Secretion Defect in Cystic Fibrosis that was held in May 1999 in Chalkidiki, Greece and was attended by about fifty scientists, research fellows and students. This conference was the first of a planned new series of conferences focusing on the underlying secretory defect and catering for the basic scientist aiming to remain abreast with recent advances in cystic fibrosis (CF) research. Since the discovery of the CF transmembrane conductance regulator protein a decade ago, research into CF has been expanding rapidly and the meeting reflected this.
ACCESSION #
16132905

 

Related Articles

  • Electrodiffusional ATP movement through CFTR and other ABC transporters. Cantiello, H. F. // Pflugers Archiv European Journal of Physiology;Nov2001 Supplement 1, Vol. 443, pS22 

    The cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the superfamily of ATP-binding cassette (ABC) transporters, also known as traffic ATPases. Recent studies from our laboratory determined that various members of the ABC family of transport proteins mediate the...

  • The CFTR-mediated protein secretion defect: pharmacological correction. McPherson, M. A.; Pereira, M. M. C.; Russell, D.; McNeilly, C. M.; Morris, R. M.; Stratford, F. L. L.; Dormer, R. L. // Pflugers Archiv European Journal of Physiology;Nov2001 Supplement 1, Vol. 443, pS121 

    The cystic fibrosis transmembrane conductance regulator (CFTR) mediates secretion of mucins and serous proteins. The aim was to correct pharmacologically the CFTR defect in protein secretion in airway gland cells and so to correct the viscous mucous secretions in cystic fibrosis (CF) airways and...

  • Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7. Shori, D. K.; Genter, T.; Hansen, J.; Koch, C.; Wyatt, H.; Kariyawasam, H. H.; Knight, R. A.; Hodson, M. E.; Kalogeridis, A.; Tsanakas, I. // Pflugers Archiv European Journal of Physiology;Nov2001 Supplement 1, Vol. 443, pS55 

    Destruction of the lungs as a consequence of recurrent infections with microorganisms such as Pseudomonas aeruginosa remains the underlying cause of most morbidity and mortality in cystic fibrosis (CF). We have hypothesized that changes in the glycosylation of key tracheal mucins such as MUC5B...

  • Molecular studies of CFTR interacting proteins. Wang, Shusheng; Li, Min // Pflugers Archiv European Journal of Physiology;Nov2001 Supplement 1, Vol. 443, pS62 

    Transport via the cystic fibrosis transmembrane conductance regulator (CFTR) is activated by its interactions with cytoplasmic cofactors, such as cAMP-activated protein kinases. CFTR activity is also known to couple to other ion channels and transporters. Although the genetic cause of human...

  • Regulation of the CFTR channel by phosphorylation. Dahan, David; Evagelidis, Alexandra; Hanrahan, John W.; Hinkson, Deborah A. R.; Jia, Yanlin; Luo, Jiexin; Zhu, Tang // Pflugers Archiv European Journal of Physiology;Nov2001 Supplement 1, Vol. 443, pS92 

    Cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels are regulated tightly by protein kinases and phosphatases. The regulatory domain of CFTR has about 20 potential sites for phosphorylation by protein kinases A (PKA) and C (PKC). The reason for this large number of sites...

  • Eicosanoid Release Is Increased by Membrane Destabilization and CFTR Inhibition in Calu-3 Cells. Borot, Florence; Vieu, Diane-Lore; Faure, Grazyna; Fritsch, Janine; Colas, Julien; Moriceau, Sandra; Baudouin-Legros, Maryvonne; Brouillard, Franck; Ayala-Sanmartin, Jesus; Touqui, Lhousseine; Chanson, Marc; Edelman, Aleksander; Ollero, Mario // PLoS ONE;2009, Vol. 4 Issue 10, p1 

    The antiinflammatory protein annexin-1 (ANXA1) and the adaptor S100A10 (p11), inhibit cytosolic phospholipase A2 (cPLA2α) by direct interaction. Since the latter is responsible for the cleavage of arachidonic acid at membrane phospholipids, all three proteins modulate eicosanoid production....

  • Sulphation of the salivary mucin MG1 (MUC-5B) is not correlated to the degree of its sialylation and is unaffected by cystic fibrosis. Shori, D. K.; Kariyawasam, H. H.; Knight, R. A.; Hodson, M. E.; Genter, T.; Hansen, J.; Koch, C.; Kalogeridis, A. // Pflugers Archiv European Journal of Physiology;Nov2001 Supplement 1, Vol. 443, pS50 

    Defective acidification of intracellular organelles, particularly the trans-Golgi network, has been proposed to explain the decreased sialylation and increased sulphation of secreted proteins in cystic fibrosis (CF). To test this hypothesis we compared expression of sulphate and sialic acid on...

  • Cystic fibrosis: addressing the transition from pediatric to adult-oriented health care. Kreindler, James L.; Miller, Victoria A. // Patient Preference & Adherence;2013, Vol. 7, p1221 

    Survival for patients with cystic fibrosis (CF) increased to nearly 40 years in 2012 from the early childhood years in the 1940s. Therefore, patients are living long enough to require transition from pediatric CF centers to adult CF centers. The goal of transition is for the young adult to be...

  • Making sense of the CF screening guidelines. Simpson, Joe Leigh // Contemporary OB/GYN;Oct2004, Vol. 49 Issue 10, p60 

    Provides practical advice on how to individualize the guidelines on cystic fibrosis screening. Pathogenesis and prevalence of the autosomal-recessive disorder; Signs and symptoms of cystic fibrosis; Identification of the genetic mutation that cause cystic fibrosis. INSET: Take-home messages.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics